Risk of stent thrombosis with bioresorbable vascular scaffolds - Authors' reply

Lancet. 2016 May 7;387(10031):1904. doi: 10.1016/S0140-6736(16)30427-5.

Authors

Salvatore Cassese¹, Adnan Kastrati²

Affiliations

¹ Deutsches Herzzentrum München, Technische Universität München, Munich 86036, Germany. Electronic address: cassese@dhm.mhn.de.
² Deutsches Herzzentrum München, Technische Universität München, Munich 86036, Germany; German Centre for Cardiovascular Research, Munich, Germany.

PMID: 27203648
DOI: 10.1016/S0140-6736(16)30427-5

No abstract available

Publication types

Letter
Comment

MeSH terms

Absorbable Implants*
Drug-Eluting Stents*
Everolimus / administration & dosage*
Female
Humans
Immunosuppressive Agents / administration & dosage*
Male
Myocardial Ischemia / drug therapy*
Tissue Scaffolds*

Substances

Immunosuppressive Agents
Everolimus